Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
337
TL;DR: EBNA- 2 transactivation of LMP1 amplifies the biological impact of EBNA-2 and underscores its central role in EBV-induced growth transformation.
read more
Abstract: Several lines of evidence are compatible with the hypothesis that Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA-2) or leader protein (EBNA-LP) affects expression of the EBV latent infection membrane protein LMP1. We now demonstrate the following. (i) Acute transfection and expression of EBNA-2 under control of simian virus 40 or Moloney murine leukemia virus promoters resulted in increased LMP1 expression in P3HR-1-infected Burkitt's lymphoma cells and the P3HR-1 or Daudi cell line. (ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression. (iii) LMP1 expression in Daudi and P3HR-1-infected cells was controlled at the mRNA level, and EBNA-2 expression in Daudi cells increased LMP1 mRNA. (iv) No other EBV genes were required for EBNA-2 transactivation of LMP1 since cotransfection of recombinant EBNA-2 expression vectors and genomic LMP1 DNA fragments enhanced LMP1 expression in the EBV-negative B-lymphoma cell lines BJAB, Louckes, and BL30. (v) An EBNA-2-responsive element was found within the -512 to +40 LMP1 DNA since this DNA linked to a chloramphenicol acetyltransferase reporter gene was transactivated by cotransfection with an EBNA-2 expression vector. (vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2. (vii) Two deletions within the EBNA-2 gene which rendered EBV transformation incompetent did not transactivate LMP1, whereas a transformation-competent EBNA-2 deletion mutant did transactivate LMP1. LMP1 is a potent effector of B-lymphocyte activation and can act synergistically with EBNA-2 to induce cellular CD23 gene expression. Thus, EBNA-2 transactivation of LMP1 amplifies the biological impact of EBNA-2 and underscores its central role in EBV-induced growth transformation.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns
humAn CARCInogens,peRsonAl hAbIts,Iarc Monographs +2 more
- 01 Jan 2012
TL;DR: PReVIously ClAssIfIed by IARC As “CARCInogenIC to humAns (gRoup 1)” And wAs deVeloped by sIx sepARAte woRkIng gRoups: phARmACeutICAls; bIologICAl Agents; ARsenIC, metAls, fIbRes, And dusts; RAdIAtIon; peRsonAl
1.3K
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
TL;DR: LMP1 is essential for EBV-mediated transformation of primary B lymphocytes, that the first 43 amino acids are critical for LMP1's function, and that codon 44-initiated L MP1 does not have a dominant negative effect on transformation.
822
Epstein–Barr virus in the pathogenesis of NPC
TL;DR: Epstein-Barr virus (EBV) is consistently detected in nasopharyngeal carcinoma (NPC) from regions of high and low incidence, suggesting that the tumors are clonal proliferations of a single cell that was initially infected with EBV.
623
Mapping of the human IL10 gene and further characterization of the 5' flanking sequence.
TL;DR: The mapping of the human IL10 gene to a discrete area of chromosome 1 is described, the definition of a potential cytokine-responsive segment 3 – 4 kilobases upstream of the transcription initiation site, and the identification of two new point mutations in the immediate promoter region with their distribution in a panel of 75 unrelated healthy individuals are described.
406
References
Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells.
TL;DR: No distinguishing features are discerned for the two geographic or pathogenic origins of the seven isolates of Epstein-Barr virus DNA molecules of each isolate.
151
An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes.
TL;DR: The basis of LMP patching in EBV-infected, transformed lymphocytes is examined and data indicate that LMP is associated with the cytoskeletal protein vimentin, which is a transducer of an LMP transmembrane effect in lymphoproliferation.
128
The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.
D Wang,D Liebowitz,Elliott Kieff +2 more
TL;DR: LMP association with the cytoskeleton in latently infected, growth-transformed lymphocytes and LMP- transformed rodent fibroblasts, correlated with the lack of both rodent cell-transforming activity and cytoskeletal association of D1LMP supports working hypothesis that cytoskletal association is important in LMP transforming activity.
125
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes.
TL;DR: It is demonstrated that the 924-base open reading frame translates a 40-kilodalton protein in vitro or in murine cells transfected with the EBNA2 cDNA under control of the murine leukemia virus long terminal repeat.
124
Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H.
TL;DR: Eight independent recombinant Epstein-Barr virus genomes, each of which was a transforming strain, were made by superinfecting cell lines containing Epstein-barr virus DNA with a nontransforming virus (P3HR1 strain).
116